Understanding the KP.3.1.1 Spike Protein of SARS-CoV-2
Author Information
Author(s): Feng Ziqi, Huang Jiachen, Baboo Sabyasachi, Diedrich Jolene K., Bangaru Sandhya, Paulson James C., Yates John R. III, Yuan Meng, Wilson Ian A., Ward Andrew B.
Primary Institution: The Scripps Research Institute
Hypothesis
How do mutations and a deletion in the KP.3.1.1 spike protein affect ACE2 binding and antibody escape?
Conclusion
The study reveals that the KP.3.1.1 spike protein mutations have minimal impact on overall spike structure and ACE2 binding, while contributing to immune evasion.
Supporting Evidence
- The KP.3.1.1 variant has a higher infectivity and greater neutralization escape compared to earlier variants.
- Mutations F456L and Q493E in the spike protein enhance binding to the human ACE2 receptor.
- The S31 deletion introduces a new glycan site that alters the spike protein's glycoform.
- Recent variants of SARS-CoV-2 are reverting to residues found in other sarbecoviruses.
Takeaway
Scientists studied a new version of the virus that causes COVID-19 to see how changes in its spike protein help it avoid the immune system and bind to human cells.
Methodology
The study used cryo-electron microscopy and mass spectrometry to analyze the spike protein structure and its interactions with ACE2.
Limitations
The study does not provide functional data from live viruses to confirm the mechanisms of immune evasion.
Statistical Information
P-Value
p=0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website